Actively Recruiting

Early Phase 1
Age: 18Years +
All Genders
NCT07012642

Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema

Led by Advanced Reconstructive Surgery Alliance · Updated on 2025-06-10

110

Participants Needed

2

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Lymphedema affects millions and currently lacks effective drug treatments, relying mainly on compression therapy. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown potential in managing obesity and diabetes, which can worsen lymphedema. Although anecdotal evidence suggests benefits of GLP-1 RAs for lymphedema patients, rigorous prospective studies are lacking. This study aims to evaluate the effectiveness of GLP-1 RAs in improving quality of life and clinical outcomes in lymphedema patients, thereby addressing a critical gap in literature and potentially offering a new treatment option.

CONDITIONS

Official Title

Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years or older
  • Unilateral upper or lower extremity lymphedema with limb volume greater than 5%
  • Body mass index (BMI) of 23 or higher
  • Oncology clearance if there is a history of cancer
Not Eligible

You will not qualify if you...

  • Moderate to severe venous insufficiency
  • Current use of GLP-1 receptor agonists
  • Known intolerance or adverse effects to GLP-1 receptor agonists
  • Medical conditions or history contraindicating GLP-1 receptor agonists, such as MEN syndrome or thyroid cancer history

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

River Center

Red Bank, New Jersey, United States, 07701

Actively Recruiting

2

260 Old Hook Rd Suite 304

Westwood, New Jersey, United States, 07675

Actively Recruiting

Loading map...

Research Team

G

Giana Truax

CONTACT

S

Saba Tasawar

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here